BioLight
Israel - Tel AvivBiotechnology
Focus: BioLight is an Israeli biotechnology company founded in 2008 specializing in ophthalmic and dermatological therapies using monochromatic phototherapy technology. The company operates as a public entity with a focused pipeline in high-unmet-need areas.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Total Funding
$20M
Open Jobs
0
About BioLight
AI assessmentNot HiringNo open roles listed right now. Follow BioLight to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Monochromatic phototherapy, Biolight®
Diabetic Foot UlcersClinical Trials (1)
NCT00859599Monochromatic Phototherapy on Diabetic Foot Ulcers
Phase 3Help build intelligence for BioLight
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.